Αναζήτηση
Eating disorders and AOD use: what clinicians need to know
Presented by Associate Professor Sarah Maguire (Director, InsideOut Institute), by attending this webinar, attendees will learn:
- How to recognise the most common eating disorder symptoms;
- Eating disorder interventions and how workers...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in the...
Πολλαπλά μειονεκτήματα και συνυπάρχουσα χρήση ουσιών και συνθήκες ψυχικής υγείας.
Η χρήση ουσιών και οι ανάγκες ψυχικής υγείας είναι δύο από τις κύριες ανησυχίες για πολλούς ανθρώπους που αντιμετωπίζουν πολλαπλά μειονεκτήματα. Γνωρίζουμε ότι οι άνθρωποι που αντιμετωπίζουν και τα δύο προβλήματα ταυτόχρονα (γνωστά και ως ...
The impact of discrimination on substance use disorders among sexual minorities
This paper aimed to review the literature regarding the impact of discrimination on substance use disorders among Sexual Minorities, with a focus on alcohol, opioids, stimulants, polydrug use, chemsex, cannabis and tobacco, as well as...
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
World Drug Report 2022
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...
Accreditation of Study Programs on Addictions in Nigerian Universities: Challenges, Opportunities, and the Need for Advocacy
INTRODUCTION:
Access to drug treatment services in Nigeria remains low due to a severe shortage in the drug treatment workforce. Plans are underway to address the workforce shortage by introducing drug addiction training programs in...
New Psychoactive Substances (NPS) Webinar Series
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...
Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors
Abstract
Cocaine addiction is a significant medical and public concern. Despite decades of research effort, development of pharmacotherapy for cocaine use disorder remains largely unsuccessful. This may be partially due to insufficient...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
New Psychoactive Substances: Reading List
Εκπαιδευτικές ενότητες του έργου NEPTUNE
Σε συνεργασία με το Βασιλικό Κολλέγιο Ψυχιάτρων, το Έργο NEPTUNE έχει αναπτύξει εκπαιδευτικές ενότητες για τη βελτίωση της κλινικής πρακτικής στη διαχείριση των βλαβών που προκύπτουν από τη χρήση φαρμάκων και νέων ψυχοδραστικών ουσιών.
Αυτ...
Καθοδήγηση για την κλινική διαχείριση των οξέων και χρόνιων βλαβών των φαρμάκων club και των νέων ψυχοδραστικών ουσιών
Αυτό το έγγραφο παρέχει καθοδήγηση σχετικά με την κλινική διαχείριση των βλαβών που προκύπτουν από οξεία δηλητηρίαση και από την επιβλαβή και εξαρτημένη χρήση ναρκωτικών και νέων ψυχοδραστικών ουσιών (NPS).
Πρόκειται για μια εκτενή και...
Εγχειρίδιο νέων ψυχοδραστικών ουσιών: Τι πρέπει να γνωρίζουν οι κλινικοί γιατροί για το NPS
Το Εγχειρίδιο Νέων Ψυχοτρόπων Ουσιών (NPS) παρέχει μια ολοκληρωμένη επισκόπηση των προκλήσεων που αντιμετωπίζουν οι κλινικοί γιατροί όταν ασχολούνται με NPS και συζητά πώς το προφίλ των ασθενών και τα κοινωνικοδημογραφικά χαρακτηριστικά...
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it...
Emerging Trends in Drugs, Addictions, and Health
Emerging Trends in Drugs, Addictions, and Health is a new international journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addiction and associated health phenomena.
The Journal has a...
New psychoactive substances: A review and updates
New psychoactive substances (NPS) are a diverse group of substances that are linked with a number of health and social harms on an individual and societal level. NPS toxicity and dependence syndromes are recognised in primary care...
UNODC Early Warning Advisory on New Psychoactive Substances
The rapid emergence of a large number of New Psychoactive Substances on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social...
New psychoactive substances (NPS)
Overview
A new psychoactive substance (NPS) is defined as 'a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member